Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor

Genes Chromosomes and Cancer

Volumn 50, Issue 10, 2011, Pages 757-764

  Antonescu, Cristina R ^a   Zhang, Lei ^a   Nielsen, G Petur ^b   Rosenberg, Andrew E ^b   Cin, Paola Dal ^c   Fletcher, Christopher D M ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CYTOGENETICS; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE REARRANGEMENT; HEMOSIDEROTIC FIBROLIPOMATOUS TUMOR; HISTOPATHOLOGY; HUMAN; INCIDENCE; KARYOTYPING; LIPOMA; MALE; MGEA5 GENE; MOLECULAR GENETICS; MORPHOLOGY; MYXOINFLAMMATORY FIBROBLASTIC SARCOMA; PATHOGENESIS; PRIORITY JOURNAL; RELIABILITY; SARCOMA; SOFT TISSUE SARCOMA; TGFBR3 GENE; TUMOR GENE; TUMOR GROWTH;

ADULT; ANTIGENS, NEOPLASM; COHORT STUDIES; CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROBLASTS; GENETIC MARKERS; HEMOSIDEROSIS; HISTONE ACETYLTRANSFERASES; HUMANS; HYALURONOGLUCOSAMINIDASE; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; KARYOTYPING; LIPOMA; MALE; MIDDLE AGED; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; UNITED STATES;

EID: 80051554317     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20897     Document Type: Article

References (22)

1. Antonescu CR, Zhang L, Chang NE, Pawel BR, Travis W, Katabi N, Edelman M, Rosenberg AE, Nielsen GP, Dal Cin P, Fletcher CD. 2010. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer 49: 1114-1124.
2. Baumhoer D, Glatz K, Schulten HJ, Fuzesi L, Fricker R, Kettelhack C, Hasenboehler P, Oberholzer M, Jundt G. 2007. Myxoinflammatory fibroblastic sarcoma: Investigations by comparative genomic hybridization of two cases and review of the literature. Virchows Arch 451: 923-928.
3. Browne TJ, Fletcher CD. 2006. Haemosiderotic fibrolipomatous tumour (so-called haemosiderotic fibrohistiocytic lipomatous tumour): Analysis of 13 new cases in support of a distinct entity. Histopathology 48: 453-461.
4. Cools J, Mentens N, Odero MD, Peeters P, Wlodarska I, Delforge M, Hagemeijer A, Marynen P. 2002. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13). Blood 99: 1776-1784.
5. Elco CP, Marino-Enriquez A, Abraham JA, Dal Cin P, Hornick JL. 2010. Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: Report of a case providing further evidence for a pathogenetic link. Am J Surg Pathol 34: 1723-1727.
6. Folpe AL, Weiss SW. 2004. Pleomorphic hyalinizing angiectatic tumor: Analysis of 41 cases supporting evolution from a distinctive precursor lesion. Am J Surg Pathol 28: 1417-1425.
7. Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, Bauer HC, Astrom K, Domanski HA, Meis JM, Kindblom LG, Panagopoulos I, Mandahl N, Mertens F. 2009. Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol 217: 716-727.
8. Helias-Rodzewicz Z, Perot G, Chibon F, Ferreira C, Lagarde P, Terrier P, Coindre JM, Aurias A. 2010. YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas. Genes Chromosomes Cancer 49: 1161-1171.
9. Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J. 2005. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: Potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11: 2702-2712.
10. Lambert I, Debiec-Rychter M, Guelinckx P, Hagemeijer A, Sciot R. 2001. Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes. Virchows Arch 438: 509-512.
11. Mansoor A, Fidda N, Himoe E, Payne M, Lawce H, Magenis RE. 2004. Myxoinflammatory fibroblastic sarcoma with complex supernumerary ring chromosomes composed of chromosome 3 segments. Cancer Genet Cytogenet 152: 61-65.
12. Marshall-Taylor C, Fanburg-Smith JC. 2000. Hemosiderotic fibrohistiocytic lipomatous lesion: Ten cases of a previously undescribed fatty lesion of the foot/ankle. Mod Pathol 13: 1192-1199.
13. Meis-Kindblom JM, Kindblom LG. 1998. Acral myxoinflammatory fibroblastic sarcoma: A low-grade tumor of the hands and feet. Am J Surg Pathol 22: 911-924.
14. Michal M. 1998. Inflammatory myxoid tumor of the soft parts with bizarre giant cells. Pathol Res Pract 194: 529-533.
15. Montgomery EA, Devaney KO, Giordano TJ, Weiss SW. 1998. Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: A distinctive lesion with features simulating inflammatory conditions, Hodgkin's disease, and various sarcomas. Mod Pathol 11: 384-391.
16. Moretti VM, de la Cruz M, Brooks JS, Lackman RD. 2010. Early pleomorphic hyalinizing angiectatic tumor: Precursor or distinct lesion? Orthopedics 33: 516.
17. Naeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA. 1995. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol 147: 1553-1558.
18. Tanaka A, Furuya A, Yamasaki M, Hanai N, Kuriki K, Kamiakito T, Kobayashi Y, Yoshida H, Koike M, Fukayama M. 1998. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Cancer Res 58: 2053-2056.
19. Thisse B, Thisse C. 2005. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol 287: 390-402.
20. Valta MP, Hentunen T, Qu Q, Valve EM, Harjula A, Seppanen JA, Vaananen HK, Harkonen PL. 2006. Regulation of osteoblast differentiation: A novel function for fibroblast growth factor 8. Endocrinology 147: 2171-2182.
21. Vaudin P, Delanoue R, Davidson I, Silber J, Zider A. 1999. TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for Vg function in wing formation. Development 126: 4807-4816.
22. Wettach GR, Boyd LJ, Lawce HJ, Magenis RE, Mansoor A. 2008. Cytogenetic analysis of a hemosiderotic fibrolipomatous tumor. Cancer Genet Cytogenet 182: 140-143.